Sidley Austin LLP has advised Bio-Techne Corporation. Sullivan & Cromwell LLP and Freshfieds have advised Merck KGaA, Darmstadt, Germany. Linklaters has advised BNP Paribas, Deutsche Bank...
Merck KGaA to Acquire Bio-Techne Corporation for US$11.3 Billion
MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Sidley has advised MacroGenics, Inc. MacroGenics, Inc. (“Bora” or “Bora Group”; TWSE: 6472; OTCQX: BORAY), a biopharmaceutical company focused on the development of antibody-based therapies for...
ARCHIMED Acquires Esperion Therapeutics in $1.1 Billion Transaction
Sidley Austin and Moelis & Company have advised ARCHIMED. Goodwin Procter and Centerview Partners have advised Esperion Therapeutics. Akin Gump has advised Pharmakon Advisors. ARCHIMED, a...
Avanos Medical to Be Acquired by American Industrial Partners in $1.27 Billion All-Cash Deal
Sidley Austin LLP, Baker Botts LLP and Ropes & Gray have advised American Industrial Partners. Alston & Bird LLP has advised Avanos Medical, Inc. Avanos Medical,...
BioCryst Pharmaceuticals to Acquire Astria Therapeutics for $920 Million
Covington & Burling LLP has advised BioCryst Pharmaceuticals, Inc., and Sidley Austin LLP has advised Astria Therapeutics, Inc. BioCryst Pharmaceuticals, Inc. has entered into a definitive...
EVERSANA Merges with Waltz Health to Create Unified Healthcare Platform
Sidley Austin has advised Waltz Health on the transaction. Waltz Health, a digital health company specializing in technologies and services that optimize prescription care decisions, has...
Sagard Healthcare Partners’ $250 Million Non-Dilutive Financings to Nuvation Bio
Cooley represented Nuvation Bio in the transaction, and Sidley Austin represented Sagard Healthcare Partners. Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the...
Inari Medical’s Merger With Stryker
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Inari Medical, while Sidley Austin is representing Stryker in the transaction. Stryker (NYSE: SYK) had...
Ardent Health’s $192 Million IPO
Sidley Austin represented Ardent Health Partners, Inc. in the offering, and Latham & Walkins represented the underwriters. Ardent Health Partners, Inc. (f/k/a Ardent Health Partners, LLC...
Carlin Consumer Health’s Acquisition of Penetrex
Sidley Austin represented Carlin Consumer Health in the transaction, and Jones Day represented American Pacific Group. Carlin Consumer Health (“Carlin”) announced its acquisition of PENETREX® (“Penetrex”)...
Amulet Capital Partners’ Acquisition of Eruptr LLC
Sidley represented H.I.G. Growth Partners on the deal. H.I.G. Growth Partners announced the sale of its portfolio company Eruptr LLC to Amulet Capital Partners, LP, a middle-market...
Denali’s US$236 Million Business Combination With Longevity Biomedical
Sidley advised Denali Capital Acquisition Corp., while Nelson Mullins Riley & Scarborough LLP assisted Longevity Biomedical. US Tiger Securities acted as business combination advisor to Denali. Denali...